New urine test could spot bladder cancer without needles or scopes
NCT ID NCT07514897
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new, non-invasive urine test that looks for a protein called CREPT in cells shed from the bladder. The goal is to see if this test can accurately detect bladder cancer and monitor if it comes back after treatment, potentially replacing uncomfortable and invasive procedures like cystoscopy. Researchers will enroll 250 people, including those with bladder cancer, benign urinary conditions, and healthy volunteers, to measure how well the test works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CREPT biomarker test (urine-based diagnostic)
What this could lead to
If successful, this could provide a simple, non-invasive urine test to catch bladder cancer early and track its return, reducing the need for invasive cystoscopies.
What could go wrong
This is an early-stage study with 250 participants, so the test may not prove accurate enough in larger, diverse populations. It is not yet a proven replacement for standard diagnostic methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Chaoyang District, 100021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••